• Ciprofloxacin Workflows for Resistance and Nanomedicine

  2026-08-24

  This practical guide positions Ciprofloxacin as both a mechanistic probe for bacterial DNA replication inhibition and a controlled payload for emerging nanotheranostic assays. It combines antimicrobial resistance research workflows with the ultrasound-activated ZIF8 platform reported for triple-negative breast cancer, emphasizing solvent control, assay comparators, and troubleshooting.

• Methicillin Sodium Salt: Designing Better Assays

  2026-08-23

  Methicillin sodium salt is more than an MSSA selection agent: it is a mechanistic probe for separating target engagement, phenotype, and resistance genotype. This guide connects PBP biology with disciplined MIC workflows and extracts assay-design lessons from the EAGLE-2 and EAGLE-3 clinical trials.

• Lanabecestat (AZD3293) BACE1 Research Workflow

  2026-08-22

  Build a practical Lanabecestat workflow that connects amyloid-beta production inhibition with synaptic-function measurements. This guide emphasizes exposure titration, paired biochemical and optical assays, and troubleshooting grounded in the finding that moderate BACE1 inhibition can reduce Aβ without necessarily disrupting synaptic transmission.

• GSK3 Inhibition as Host-Directed TB Therapy

  2026-08-22

  The 2024 iScience study identifies glycogen synthase kinase 3 inhibition as a host-directed strategy for restricting intracellular Mycobacterium tuberculosis growth. By combining chemical screening, genetic perturbation, macrophage infection models, and phospho-proteomics, the work connects GSK3 signaling with pathogen-driven macrophage dysfunction and apoptosis.

• U 46619: TP Receptor Agonist Guide

  2026-08-21

  U 46619, also called 11,9 epoxymethano-prostaglandin H2, is a synthetic TP-receptor agonist used to model platelet activation and vascular responses. Product-reported EC50 values distinguish early platelet shape change and myosin light-chain phosphorylation from later serotonin release, aggregation, and fibrinogen-receptor binding.

• Digoxin Workflows for Cardiac and Viral Research

  2026-08-20

  Digoxin supports two distinct research programs: Na+/K+ ATPase-driven cardiac contractility modulation and cell-selective inhibition of chikungunya virus infection. This practical guide connects model selection, dosing, controls, and troubleshooting while separating product-backed findings from workflow recommendations.

• Bromodomain Inhibitor (+)-JQ1: BET Workflows

  2026-08-20

  Bromodomain Inhibitor, (+)-JQ1 converts BET biology into practical workflows for apoptosis, chromatin, cancer combination, inflammation, and reproductive studies. This guide links BRD4-focused mechanism with assay design, dosing controls, and troubleshooting strategies that improve reproducibility.

• CHI3L1-IN-5: CNS Neuroinflammation Workflows

  2026-08-19

  CHI3L1-IN-5 (Compound Z17) enables a paired workflow: measure CHI3L1-mediated NF-κB suppression while testing astrocyte Aβ uptake and lysosomal recovery. Its CNS-oriented physicochemical profile makes it useful for mechanism-led neuroinflammation studies, provided exposure, vehicle, and functional rescue are interpreted separately.

• PX-478 and Prenatal Hypoxia-Induced ASD-Like Behavior

  2026-08-19

  A 2024 rat study examined whether PX-478-mediated HIF-1α inhibition could reduce autism-like behavioral and hippocampal abnormalities after prenatal hypoxia. The findings connect improved behavior with reduced hippocampal HIF-1α, increased PTEN, lower circulating VEGF, and treatment-timing-dependent safety signals.

• T0070907: Practical PPARγ Antagonist Guide

  2026-08-18

  T0070907 is a nanomolar PPARγ antagonist for separating receptor-dependent transcription from downstream phenotypes in adipogenesis, inflammatory macrophage, and cancer models. This guide translates its covalent mechanism into practical workflows, controls, and troubleshooting strategies for reproducible pathway studies.

• Partial BACE1 Inhibition and Synaptic Function

  2026-08-18

  Satir et al. examined whether moderate β-secretase inhibition can reduce amyloid-beta secretion without impairing neuronal communication. Using primary rat cortical cultures, optical electrophysiology, and three BACE inhibitors, the study found that reductions below 50% preserved synaptic transmission, whereas stronger inhibition was associated with functional suppression.

• Geneticin: Selection and Antiviral Workflows

  2026-08-17

  Geneticin, also called G418 Sulfate, combines dependable neomycin-resistance selection with a distinct application in Dengue virus research. This practical guide connects kill-curve design, stable cell engineering, extracellular-vesicle studies, and assay troubleshooting while separating established evidence from workflow recommendations.

• Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic

  2026-08-17

  The Annexin V-Cy5/DAPI Apoptosis Kit converts phosphatidylserine exposure and membrane integrity into an interpretable cell-death map. This article connects the assay to P2RX1-driven mitochondrial apoptosis in Ph+ ALL while defining practical controls, readout limits, and workflow decisions.

• AMG 9810 for Reliable TRPV1 Assays

  2026-08-16

  Learn how AMG 9810 (SKU B7018) can improve mechanistic interpretation of calcium influx, CGRP release, viability, and cytotoxicity experiments involving TRPV1. This scenario-based guide covers solvent controls, assay compatibility, workflow parameters, metabolic-stress confounders, and practical product-selection criteria.

• E-64d Workflows for Calpain and Cathepsin Research

  2026-08-15

  E-64d enables intracellular inhibition of calpain and several lysosomal cysteine proteases, making it useful for dissecting platelet activation, apoptosis, lysosomal cell death, and seizure-related injury. This practical guide connects mechanism to experimental workflows, controls, troubleshooting, and interpretation limits.

7832 records 1/523 page Next 12345 下5页 Last page